Dow Up 0.08% Nasdaq Down 0.30%

InVivo Therapeutics Holdings Corp. (NVIV)

-Other OTC
0.54 Up 0.04(7.94%) 3:41PM EDT
Prev Close:0.50
Open:0.52
Bid:N/A
Ask:N/A
1y Target Est:3.00
Beta:1.13
Next Earnings Date:N/A
Day's Range:0.50 - 0.55
52wk Range:0.47 - 2.67
Volume:120,899
Avg Vol (3m):262,095
Market Cap:50.42M
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVIV

Comparison

Symbol% ChgMkt Cap
NVIVUp 7.94%50.42M
ACORDown 1.38%1.23B
ALSE 0.00%995.64K
STEMDown 8.45%89.23M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Invivo Therapeutics Holdings Corp., a development stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injuries (SCI). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback